Neumora Therapeutics Inc [NASDAQ: NMRA] price plunged by -3.51 percent to reach at -$0.08.
The one-year NMRA stock forecast points to a potential upside of 87.24. The average equity rating for NMRA stock is currently 1.44, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Neumora Therapeutics Inc [NMRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NMRA shares is $17.24 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NMRA stock is a recommendation set at 1.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Neumora Therapeutics Inc shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on January 02, 2025. While these analysts kept the previous recommendation, JP Morgan dropped their target price from $18 to $15. The new note on the price target was released on November 05, 2024, representing the official price target for Neumora Therapeutics Inc stock. Previously, the target price had yet another raise to $30, while H.C. Wainwright analysts kept a Buy rating on NMRA stock.
The Average True Range (ATR) for Neumora Therapeutics Inc is set at 0.88 The Price to Book ratio for the last quarter was 1.10, with the Price to Cash per share for the same quarter was set at 2.12.
NMRA Stock Performance Analysis:
Neumora Therapeutics Inc [NMRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.73. With this latest performance, NMRA shares dropped by -79.21% in over the last four-week period, additionally sinking by -81.48% over the last 6 months – not to mention a drop of -84.72% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NMRA stock in for the last two-week period is set at 20.69, with the RSI for the last a single of trading hit 17.83, and the three-weeks RSI is set at 23.81 for Neumora Therapeutics Inc [NMRA]. The present Moving Average for the last 50 days of trading for this stock 9.24, while it was recorded at 2.30 for the last single week of trading, and 10.93 for the last 200 days.
Insight into Neumora Therapeutics Inc Fundamentals:
Neumora Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.98 and a Current Ratio set at 10.98.
Neumora Therapeutics Inc [NMRA] Institutonal Ownership Details
There are presently around $64.29%, or 88.64%% of NMRA stock, in the hands of institutional investors.
